Clinical Study
Alendronate as an Effective Treatment for Bone Loss and Vascular Calcification in Kidney Transplant Recipients
Table 2
Biochemical parameters and bone turnover markers at baseline.
| ||||||||||||||||||||||||||||||||||||||||||||
Ca: serum calcium; P: serum phosphate; wPTH: serum whole parathyroid hormone; BAP: serum bone-specific alkaline phosphatase; 1, 25-(OH)2vitD: serum 1, 25-dihydroxycholecalciferol; NTx: serum N-terminal telopeptides of bone-specific type I collagen; eGFR: estimated glomerular filtration rate; NS: not significant. |